These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10225582

  • 1. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
    Krumpe PE, Cohn S, Garreltes J, Ramirez J, Coulter H, Haverstock D, Echols R.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():117-28. PubMed ID: 10225582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.
    Finch R, Schürmann D, Collins O, Kubin R, McGivern J, Bobbaers H, Izquierdo JL, Nikolaides P, Ogundare F, Raz R, Zuck P, Hoeffken G.
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1746-54. PubMed ID: 12019085
    [Abstract] [Full Text] [Related]

  • 4. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
    Fink MP, Snydman DR, Niederman MS, Leeper KV, Johnson RH, Heard SO, Wunderink RG, Caldwell JW, Schentag JJ, Siami GA.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):547-57. PubMed ID: 8203853
    [Abstract] [Full Text] [Related]

  • 5. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.
    Anzueto A, Niederman MS, Haverstock DC, Tillotson GS.
    Clin Ther; 1997 Mar; 19(5):989-1001. PubMed ID: 9385486
    [Abstract] [Full Text] [Related]

  • 7. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA, Eiferman RA, Caldwell DR, Rosenwasser GO, Santos CI, Katz HR, Badrinath SS, Reddy MK, Adenis JP, Klauss V.
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.
    Johnson PR, Liu Yin JA, Tooth JA.
    J Antimicrob Chemother; 1992 Aug; 30(2):203-14. PubMed ID: 1399929
    [Abstract] [Full Text] [Related]

  • 11. Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.
    Giamarellou H, Bassaris HP, Petrikkos G, Busch W, Voulgarelis M, Antoniadou A, Grouzi E, Zoumbos N.
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3264-71. PubMed ID: 11083625
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
    Read RC, Kuss A, Berrisoul F, Kearsley N, Torres A, Kubin R.
    Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
    [Abstract] [Full Text] [Related]

  • 13. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
    Solomkin JS, Reinhart HH, Dellinger EP, Bohnen JM, Rotstein OD, Vogel SB, Simms HH, Hill CS, Bjornson HS, Haverstock DC, Coulter HO, Echols RM.
    Ann Surg; 1996 Mar; 223(3):303-15. PubMed ID: 8604912
    [Abstract] [Full Text] [Related]

  • 14. Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults.
    Yellin AE, Hassett JM, Fernandez A, Geib J, Adeyi B, Woods GL, Teppler H, 004 Intra-abdominal Infection Study Group.
    Int J Antimicrob Agents; 2002 Sep; 20(3):165-73. PubMed ID: 12385694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V, Pavletich K.
    Drugs Exp Clin Res; 1994 Sep; 20(5):209-14. PubMed ID: 7875058
    [Abstract] [Full Text] [Related]

  • 17. Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis.
    Amodio-Groton M, Madu A, Madu CN, Briceland LL, Seligman M, McMaster P, Miller MH.
    Ann Pharmacother; 1996 Jun; 30(6):596-602. PubMed ID: 8792944
    [Abstract] [Full Text] [Related]

  • 18. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L, Paul M, Poznanski O, Drucker M, Samra Z, Konigsberger H, Pitlik SD.
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [Abstract] [Full Text] [Related]

  • 19. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
    Wacha H, Warren B, Bassaris H, Nikolaidis P, Intra-Abdominal Infections Study Group.
    Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of high dose intravenous ciprofloxacin in the treatment of bacterial pneumonia. Italian Ciprofloxacin Study Group.
    Periti P, Mazzei T, Curti ME.
    Int J Antimicrob Agents; 1998 Aug; 10(3):215-22. PubMed ID: 9832282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.